Table 2 |
|||||
|
Optimal biomarker cut-off values for receiver operating characteristic curve sensitivity, specificity, positive likelihood ratio (LR(+)) and negative likelihood ratio (LR(-)) at the chosen cutoffs. |
|||||
|
Cut-off |
Sensitivity |
Specificity |
LR(+) |
LR(-) |
|
|
|
|||||
|
Angiopoietin-2 |
ng/mL |
# (95% CI) |
# (95% CI) |
# (95% CI) |
# (95% CI) |
|
|
|||||
|
UM vs. SM |
1.43 |
0.694 (0.531-0.820) |
0.786 (0.676-0.866) |
3.241 (1.969-5.333) |
0.389 (0.234-0.646) |
|
UM vs. CM |
1.33 |
0.759 (0.659-0.836) |
0.771 (0.661-0.854) |
3.319 (2.124-5.186) |
0.313 (0.211-0.464) |
|
UM vs. (CM+SM) |
1.33 |
0.740 (0.656-0.809) |
0.771 (0.661-0.854) |
3.237 (2.078-5.041) |
0.337 (0.244-0.466) |
|
SM vs. CM |
3.14 |
0.472 (0.319-0.630) |
0.644 (0.539-0.736) |
1.325 (0.848-2.070) |
0.820 (0.580-1.159) |
|
|
|||||
|
Angiopoietin-1 |
ng/mL |
# (95% CI) |
# (95% CI) |
# (95% CI) |
# (95% CI) |
|
|
|||||
|
UM vs. SM |
12.38 |
0.861 (0.713-0.939) |
0.852 (0.757-0.921) |
6.028 (3.346- 10.859) |
0.162 (0.071-0.368) |
|
UM vs. CM |
15.86 |
0.713 (0.610-0.797) |
0.743 (0.630-0.831) |
2.771 (1.821-4.218) |
0.387 (0.270-0.554) |
|
UM vs. (CM+SM) |
15.16 |
0.707 (0.622-0.781) |
0.771 (0.661-0.854) |
3.094 (1.983-4.830) |
0.379 (0.280-0.514) |
|
SM vs. CM |
11.21 |
0.722 (0.560-0.842) |
0.655 (0.551-0.747) |
2.094 (1.471-2.982) |
0.424 (0.245-0.734) |
|
|
|||||
|
Ratio |
# (95% CI) |
# (95% CI) |
# (95% CI) |
# (95% CI) |
|
|
|
|||||
|
UM vs. SM |
0.082 |
0.806 (0.650-0.903) |
0.829 (0.724-0.899) |
4.699 (2.74-8.059) |
0.235 (0.120-0.460) |
|
UM vs. CM |
0.080 |
0.782 (0.684-0.856) |
0.829 (0.724-0.899) |
4.559 (2.692-7.722) |
0.264 (0.175-0.398) |
|
UM vs. (CM+SM) |
0.080 |
0.789 (0.708-0.852) |
0.829 (0.723-0.899) |
4.600 (2.727-7.762) |
0.255 (0.178-0.365) |
|
SM vs. CM |
0.448 |
0.444 (0.295-0.604) |
0.828 (0.735-0.893) |
2.578 (1.432-4.639) |
0.671 (0.494-0.913) |
|
|
|||||
|
Conroy et al. Malaria Journal 2009 8:295 doi:10.1186/1475-2875-8-295 |
|||||